Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
New York State Workers' Compensation Board Announces Implementation Delay
The New York State Workers' Compensation Board announced on Monday, May 24, 2021, a delay in the implementation of the drug formulary for refills a
Knee Injuries: Trends and Advances [Recording]
On-Demand
Knee injuries make up a large percentage of medical insurance and health care claims in the orthopedic field.
The Truth About Mental Health and Claim Costs
Traditionally, the term mental health has been treated as a claims pariah in workers’ comp, as it’s been associated with delaying recovery and send
Transportation and translation: an unlikely but powerful duo
Recently, the Sounding Board sat down with Jim Begg, Vice President of National Accounts for Apricus, to talk about transportation and translation
Understanding Mental Health Misconceptions in Workers’ Comp
Hello and welcome to the first of a four-part podcast compliment to the Mitchell | Genex | Coventry thought leadership eBook, Strategies for Co
FDA Approves Higher Dose Naloxone, Kloxxado
Naloxone has been known by different brand names over the years as the primary treatment of opioid overdose.